comparemela.com

Latest Breaking News On - Atish majumdar - Page 1 : comparemela.com

AstraZeneca Pharma India, Mankind Pharma ink pact to distribute asthma medicine

AstraZeneca Pharma India Ltd and Mankind Pharma Ltd on Monday said they have entered into an agreement for exclusive distribution of the Symbicort brand, an asthma medicine, in India. Symbicort is owned by AstraZeneca, which will retain the intellectual property rights and will continue to be the

AstraZeneca: Mankind Pharma enters exclusive pact to distribute AstraZeneca s anti-asthma drug Symbicort in India

AstraZeneca Pharma India has partnered with Mankind Pharma to exclusively distribute its anti-asthma drug Symbicort in India. AstraZeneca will retain the intellectual property rights to Symbicort and continue as the marketing authorization holder. Symbicort, a top-selling product globally for AstraZeneca, recorded sales of around $2.4 billion in 2023.

AstraZeneca Pharma, Mankind Pharma partner to accelerate access to asthma medicine | Central India s Premier English Daily

AstraZeneca Pharma, Mankind Pharma partner to accelerate access to asthma medicine | Central India s Premier English Daily
centralchronicle.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from centralchronicle.com Daily Mail and Mail on Sunday newspapers.

AstraZeneca Pharma India and Mankind Pharma partner to accelerate access to asthma medicine

AstraZeneca Pharma India and Mankind Pharma partner to accelerate access to asthma medicine
biospectrumindia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biospectrumindia.com Daily Mail and Mail on Sunday newspapers.

Latest News | Mankind Pharma Invests in UK-based Firm

Get latest articles and stories on Latest News at LatestLY. Mankind Pharma on Monday said it has invested in a UK-based clinical stage specialty pharmaceutical company, Actimed Therapeutics. Latest News | Mankind Pharma Invests in UK-based Firm.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.